These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 31662821)

  • 1. Precision medicine in gastric cancer.
    Bonelli P; Borrelli A; Tuccillo FM; Silvestro L; Palaia R; Buonaguro FM
    World J Gastrointest Oncol; 2019 Oct; 11(10):804-829. PubMed ID: 31662821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives.
    Tirino G; Pompella L; Petrillo A; Laterza MM; Pappalardo A; Caterino M; Orditura M; Ciardiello F; Galizia G; De Vita F
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
    Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
    World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.
    Narita Y; Muro K
    Expert Opin Drug Saf; 2017 Mar; 16(3):319-327. PubMed ID: 27976952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overview of Chemotherapy for Gastric Cancer.
    Sato Y; Okamoto K; Kida Y; Mitsui Y; Kawano Y; Sogabe M; Miyamoto H; Takayama T
    J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36835872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalised Treatment in Gastric Cancer: Myth or Reality?
    Tarazona N; Gambardella V; Huerta M; Roselló S; Cervantes A
    Curr Oncol Rep; 2016 Jul; 18(7):41. PubMed ID: 27215435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets.
    Kankeu Fonkoua L; Yee NS
    Biomedicines; 2018 Mar; 6(1):. PubMed ID: 29522457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison and applicability of molecular classifications for gastric cancer.
    Serra O; Galán M; Ginesta MM; Calvo M; Sala N; Salazar R
    Cancer Treat Rev; 2019 Jul; 77():29-34. PubMed ID: 31195213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric Carcinoma at the Era of Targeted Therapies.
    Dreanic J; Dhooge M; Sion E; Brezault C; Chaussade S; Coriat R
    Curr Drug Targets; 2016; 17(15):1818-1826. PubMed ID: 25944013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
    Ali SM; Sanford EM; Klempner SJ; Rubinson DA; Wang K; Palma NA; Chmielecki J; Yelensky R; Palmer GA; Morosini D; Lipson D; Catenacci DV; Braiteh F; Erlich R; Stephens PJ; Ross JS; Ou SH; Miller VA
    Oncologist; 2015 May; 20(5):499-507. PubMed ID: 25882375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeted therapy in advanced gastric carcinoma: the future is beginning.
    Schinzari G; Cassano A; Orlandi A; Basso M; Barone C
    Curr Med Chem; 2014; 21(8):1026-38. PubMed ID: 24304282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Molecular Targeted Therapy in Advanced Gastric Cancer: A Comprehensive Review of Therapeutic Mechanism, Clinical Trials, and Practical Application.
    Li K; Li J
    Gastroenterol Res Pract; 2016; 2016():4105615. PubMed ID: 26880889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity in Gastric Cancer: From Pure Morphology to Molecular Classifications.
    Gullo I; Carneiro F; Oliveira C; Almeida GM
    Pathobiology; 2018; 85(1-2):50-63. PubMed ID: 28618420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma.
    Garrido M
    Expert Rev Anticancer Ther; 2016 Oct; 16(10):1005-10. PubMed ID: 27582051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive biomarkers for targeted and cytotoxic agents in gastric cancer for personalized medicine.
    Wang S; Yuan L
    Biosci Trends; 2016 Jul; 10(3):171-80. PubMed ID: 27251446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic gastric cancer - focus on targeted therapies.
    Meza-Junco J; Sawyer MB
    Biologics; 2012; 6():137-46. PubMed ID: 22807624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
    Díaz-Serrano A; Angulo B; Dominguez C; Pazo-Cid R; Salud A; Jiménez-Fonseca P; Leon A; Galan MC; Alsina M; Rivera F; Plaza JC; Paz-Ares L; Lopez-Rios F; Gómez-Martín C
    Oncologist; 2018 Sep; 23(9):1092-1102. PubMed ID: 29700210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for Gastric Cancer: A Focus on Immune Checkpoints.
    Alsina M; Moehler M; Hierro C; Guardeño R; Tabernero J
    Target Oncol; 2016 Aug; 11(4):469-77. PubMed ID: 26880697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lapatinib.
    Voigtlaender M; Schneider-Merck T; Trepel M
    Recent Results Cancer Res; 2018; 211():19-44. PubMed ID: 30069757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.